XORTX Therapeutics Inc.
News
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
Globe Newswire CALGARY, Alberta, Sept. 12, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the Company ) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...\n more…
XORTX Prepares for Shareholders' Vote on Key Resolutions
TipRanks Financial Blog XORTX Therapeutics Inc (TSE:XRTX) has released an update. XORTX Therapeutics Inc. is gearing up for its Annual General and Special Meeting on September 12, 2024, ur...\n more…
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
Globe Newswire CALGARY, Alberta, Sept. 06, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the Company ) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...\n more…
XORTX Recommended by ISS for Shareholder Approval
TipRanks Financial Blog XORTX Therapeutics Inc (TSE:XRTX) has released an update. XORTX Therapeutics Inc., a pharmaceutical company specializing in treatments for progressive kidney diseas...\n more…
Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders
Globe Newswire CALGARY, Alberta, Sept. 03, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the Company ) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...\n more…
